
Early quantification of salivary gland function after radioiodine therapy
Author(s) -
Karan Singh Tanwar,
Nivedita Rana,
Bhagwant Rai Mittal,
Anish Bhattacharya
Publication year - 2021
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/ijnm.ijnm_158_20
Subject(s) - medicine , scintigraphy , salivary gland , submandibular gland , thyroid , nuclear medicine , pertechnetate , radioiodine therapy , saliva , parotid gland , thyroid carcinoma , urology , pathology
Radioiodine (I-131) is used as an effective noninvasive treatment for thyroid malignancies. Salivary gland is one of the most affected nontarget organs. The present study aims to perform early quantification of salivary gland function after I-131 therapy (RIT) for thyroid cancer considering I-131 down-scatter in the Tc-99m window.